Scarica l'app Stockscreener
339.30
0.56%
1.88
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$337.42
Aprire:
$340.26
Volume 24 ore:
1.47M
Relative Volume:
0.56
Capitalizzazione di mercato:
$183.22B
Reddito:
$37.30B
Utile/perdita netta:
$7.80B
Rapporto P/E:
23.60
EPS:
14.3793
Flusso di cassa netto:
$8.60B
1 W Prestazione:
+3.98%
1M Prestazione:
-1.91%
6M Prestazione:
+0.52%
1 anno Prestazione:
+24.79%
Intervallo 1D:
$338.40
$343.80
Intervallo di 1 settimana:
$320.96
$343.80
Portata 52W:
$267.83
$391.29
Amgen Inc Stock (AMGN) Company Profile
Nome
Amgen Inc
Settore
Industria
Telefono
(805)447-1000
Indirizzo
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN vs LLY, JNJ, ABBV, MRK, AZN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
339.30 | 182.21B | 37.30B | 7.80B | 8.60B | 14.38 |
LLY
Lilly Eli Co
|
1,065.00 | 928.88B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
234.34 | 557.82B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
215.70 | 378.98B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
122.41 | 286.20B | 65.51B | 8.93B | 14.12B | 3.5532 |
AZN
Astrazeneca Plc
|
187.03 | 294.27B | 60.48B | 10.40B | 8.05B | 3.3297 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-21 | Iniziato | Canaccord Genuity | Hold |
| 2026-03-10 | Iniziato | Jefferies | Hold |
| 2026-02-20 | Iniziato | Barclays | Equal Weight |
| 2026-01-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | Ripresa | UBS | Buy |
| 2025-12-05 | Aggiornamento | Erste Group | Hold → Buy |
| 2025-11-24 | Ripresa | Truist | Hold |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-09-03 | Ripresa | Raymond James | Mkt Perform |
| 2025-05-20 | Ripresa | Guggenheim | Neutral |
| 2025-04-22 | Ripresa | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Ripresa | BofA Securities | Underperform |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-14 | Iniziato | Citigroup | Neutral |
| 2024-10-17 | Iniziato | Bernstein | Outperform |
| 2024-10-14 | Downgrade | Truist | Buy → Hold |
| 2024-09-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Ripresa | Raymond James | Mkt Perform |
| 2024-02-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-11-02 | Aggiornamento | Truist | Hold → Buy |
| 2023-10-20 | Ripresa | JP Morgan | Neutral |
| 2023-10-17 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Ripresa | BofA Securities | Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-04-24 | Reiterato | Oppenheimer | Outperform |
| 2023-03-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Reiterato | Truist | Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Underperform |
| 2022-10-31 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Iniziato | SVB Leerink | Mkt Perform |
| 2022-02-09 | Reiterato | Barclays | Equal Weight |
| 2022-02-09 | Reiterato | Jefferies | Buy |
| 2022-02-09 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Reiterato | Oppenheimer | Outperform |
| 2022-02-09 | Reiterato | Wells Fargo | Equal Weight |
| 2022-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
| 2021-12-06 | Iniziato | Goldman | Buy |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-09-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Iniziato | Daiwa Securities | Buy |
| 2020-10-28 | Iniziato | UBS | Neutral |
| 2020-10-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Aggiornamento | Truist | Hold → Buy |
| 2020-10-09 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Downgrade | Truist | Buy → Hold |
| 2020-10-08 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Ripresa | Guggenheim | Neutral |
| 2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
| 2020-03-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Iniziato | Barclays | Equal Weight |
| 2020-01-31 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-17 | Ripresa | Morgan Stanley | Overweight |
| 2019-11-12 | Iniziato | SunTrust | Buy |
| 2019-11-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-19 | Downgrade | Mizuho | Buy → Neutral |
| 2019-05-23 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Amgen Inc Borsa (AMGN) Ultime notizie
Wealthquest Corp Acquires Shares of 3,374 Amgen Inc. $AMGN - MarketBeat
Legal & General Group Plc Boosts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Bought by New Age Alpha Advisors LLC - MarketBeat
Simplify Asset Management Inc. Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (AMGN) Stock Analysis: Strong ROE and Promising Outlook in the Healthcare Sector - DirectorsTalk Interviews
Amgen Inc. $AMGN Shares Sold by Swedbank AB - MarketBeat
Amgen Inc. $AMGN is Smead Capital Management Inc.'s 5th Largest Position - MarketBeat
Amgen stock (US0311621009): Shares edge lower after early-February trade update - AD HOC NEWS
Amgen stock (US0311621009): earnings beat and leadership change put biotech giant in focus - AD HOC NEWS
Does Amgen’s CFO Transition and Board Structure Shape a New Governance Story for AMGN? - simplywall.st
Amgen Inc. (AMGN) is attracting investor attention: Here is what you should know - MSN
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It - MSN
Legato Capital Management LLC Acquires Shares of 8,328 Amgen Inc. $AMGN - MarketBeat
Axxcess Wealth Management LLC Raises Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Americana Partners LLC - MarketBeat
Amgen Inc. stock (US0311621009): weight-loss data and obesity ambitions move into focus - AD HOC NEWS
Amgen (NASDAQ:AMGN) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Amgen Inc. (NASDAQ: AMGN) Stock Trades Near $330 as Japan Drug Safety Crisis Raises Concerns - foreignpolicyjournal.com
Amgen Inc. stock (US0311621009): obesity data, Horizon deal and pipeline put focus back on the biote - AD HOC NEWS
Keudell Morrison Wealth Management Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Rx Rundown: Parabilis Medicines, Boston Scientific, Amgen and more - Medical Marketing and Media
Global Retirement Partners LLC Purchases 5,691 Shares of Amgen Inc. $AMGN - MarketBeat
A Look At Amgen (AMGN) Valuation As Tavneos Safety Concerns And Withdrawal Requests Escalate - Yahoo Finance
Amgen Inc. Stock 12‑Month Price Target Cut to $352.32, Implies 4% Upside - TradingView
Amgen stock (US0311621009): Q1 revenue tops estimates, CFO change keeps debt in focus - AD HOC NEWS
Amgen (AMGN) director Amy E. Miles awarded 665 RSUs, now holds 5,640 shares - Stock Titan
Amgen (AMGN) director Ellen Kullman receives 665-share RSU equity grant - Stock Titan
Amgen (NASDAQ: AMGN) director granted 665 RSUs in stock award - Stock Titan
Amgen (NASDAQ: AMGN) director granted 665-share equity award, now holds 18,284 - Stock Titan
Amgen Shareholders Reaffirm Board, Pay and Auditors - The Globe and Mail
Amgen (AMGN) director Omar Ishrak receives 665-share stock grant in Form 4 - Stock Titan
Amgen (AMGN) director Charles Holley receives 665-share RSU grant and reports 12.8K direct holdings - Stock Titan
Amgen (AMGN) director Garland receives 665 RSUs that vest immediately - Stock Titan
Amgen (AMGN) director receives 665 RSUs in immediate stock grant - Stock Titan
Amgen (NASDAQ: AMGN) director Brian Druker receives 665-share RSU grant - Stock Titan
Amgen (AMGN) director Michael V. Drake receives 665-share RSU award - Stock Titan
Amgen (AMGN) director receives 665-share RSU stock grant award - Stock Titan
Amgen’s ‘boomerang’ CFO reaps $12.5M in cash, retention bonuses - CFO Dive
Amgen Wants To Preserve Right To Seek Double Tax Relief - Law360
Amgen CFO Change Puts Focus On Debt, Growth And Capital Discipline - simplywall.st
Amgen Drug Gets New Warnings in Japan After Patient Deaths - WSJ
Amgen's Q1 earnings top estimates, 16 drugs deliver double-digit gains - MSN
CytomX Therapeutics to Present at Upcoming June Investor Conferences - GlobeNewswire Inc.
The Escalator: Amgen, CG Life, Cosette Pharmaceuticals and more - Medical Marketing and Media
IFP Advisors Inc Has $3.92 Million Stake in Amgen Inc. $AMGN - MarketBeat
Liquidity Mapping Around (AMGN) Price Events - Stock Traders Daily
Amgen Inc. (AMGN): Navellier’s Long-Term Pick on Pipeline Strength and Sales Growth - Insider Monkey
ABN Amro Investment Solutions Acquires 13,431 Shares of Amgen Inc. $AMGN - MarketBeat
AMGN Stock Price, Quote & Chart | AMGEN INC (NASDAQ:AMGN) - ChartMill
Amgen's CFO resigns – a successor has been named - medwatch.com
Amgen Inc. (NASDAQ:AMGN) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Amgen Inc Azioni (AMGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.28%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):